Welch Group LLC raised its holdings in Stryker Co. (NYSE:SYK) by 1.5% during the 1st quarter, Holdings Channel reports. The institutional investor owned 3,774 shares of the medical technology company’s stock after acquiring an additional 54 shares during the quarter. Welch Group LLC’s holdings in Stryker were worth $745,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Westside Investment Management Inc. grew its position in shares of Stryker by 38.7% in the 4th quarter. Westside Investment Management Inc. now owns 233 shares of the medical technology company’s stock valued at $37,000 after acquiring an additional 65 shares during the period. First Hawaiian Bank grew its position in shares of Stryker by 0.5% in the 1st quarter. First Hawaiian Bank now owns 12,570 shares of the medical technology company’s stock valued at $2,483,000 after acquiring an additional 67 shares during the period. DAVENPORT & Co LLC grew its position in shares of Stryker by 1.6% in the 4th quarter. DAVENPORT & Co LLC now owns 4,340 shares of the medical technology company’s stock valued at $680,000 after acquiring an additional 70 shares during the period. Wedbush Securities Inc. grew its position in shares of Stryker by 1.6% in the 4th quarter. Wedbush Securities Inc. now owns 4,497 shares of the medical technology company’s stock valued at $705,000 after acquiring an additional 70 shares during the period. Finally, First Allied Advisory Services Inc. grew its position in shares of Stryker by 0.4% in the 4th quarter. First Allied Advisory Services Inc. now owns 16,700 shares of the medical technology company’s stock valued at $2,625,000 after acquiring an additional 71 shares during the period. Hedge funds and other institutional investors own 74.58% of the company’s stock.

SYK has been the subject of a number of analyst reports. Morgan Stanley decreased their price objective on shares of Stryker from $212.00 to $197.00 and set an “overweight” rating for the company in a research report on Wednesday, January 2nd. SunTrust Banks lifted their price objective on shares of Stryker to $205.00 and gave the company a “positive” rating in a research report on Monday, February 4th. Royal Bank of Canada lifted their price objective on shares of Stryker from $184.00 to $204.00 and gave the company an “outperform” rating in a research report on Monday, March 11th. Credit Suisse Group raised shares of Stryker to an “outperform” rating in a research report on Thursday, January 31st. Finally, Wells Fargo & Co lifted their price objective on shares of Stryker from $214.00 to $219.00 and gave the company an “outperform” rating in a research report on Monday, April 1st. Eight analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $192.13.

Shares of SYK stock traded up $0.75 during midday trading on Monday, hitting $193.42. 1,399,936 shares of the company were exchanged, compared to its average volume of 1,349,729. The company has a market capitalization of $72.88 billion, a price-to-earnings ratio of 26.46, a PEG ratio of 2.40 and a beta of 0.88. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.41 and a current ratio of 2.02. Stryker Co. has a 52 week low of $144.75 and a 52 week high of $199.85.

Stryker (NYSE:SYK) last announced its earnings results on Tuesday, January 29th. The medical technology company reported $2.18 EPS for the quarter, topping the consensus estimate of $2.15 by $0.03. The business had revenue of $3.80 billion during the quarter, compared to the consensus estimate of $3.73 billion. Stryker had a net margin of 26.12% and a return on equity of 27.60%. Sell-side analysts forecast that Stryker Co. will post 8.13 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 30th. Stockholders of record on Friday, March 29th will be given a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 1.08%. The ex-dividend date of this dividend is Thursday, March 28th. Stryker’s payout ratio is presently 28.45%.

In other news, VP M Kathryn Fink sold 180 shares of the business’s stock in a transaction that occurred on Monday, February 4th. The shares were sold at an average price of $176.77, for a total value of $31,818.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Timothy J. Scannell sold 5,282 shares of the business’s stock in a transaction that occurred on Wednesday, January 16th. The shares were sold at an average price of $163.50, for a total transaction of $863,607.00. The disclosure for this sale can be found here. Insiders sold a total of 131,071 shares of company stock valued at $24,689,161 over the last 90 days. Corporate insiders own 7.20% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Welch Group LLC Acquires 54 Shares of Stryker Co. (SYK)” was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another domain, it was copied illegally and republished in violation of international copyright & trademark laws. The correct version of this article can be read at https://www.thecerbatgem.com/2019/04/15/welch-group-llc-acquires-54-shares-of-stryker-co-syk.html.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.

Featured Article: Do closed-end mutual funds pay dividends?

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.